Analysis of Human ALS Tissues and Registry of ALS Patients

Recruiting now

Conditions studied: Amyotrophic Lateral Sclerosis

In brief

Amyotrophic Lateral Sclerosis (ALS), often referred to as Lou Gehrig's Disease, is a progressive, terminal condition of muscle weakness that is associated with degeneration of neurons in the spinal cord and brain. This devastating disorder afflicts people in the prime of their lives. At the present time, there are no cures for this disorder, and current treatments are marginal at best. Despite years of intensive research, a fundamental understanding of this disease is still lacking. There is a need to identify both reliable markers of disease progression and effective treatments. The goal of this research is to bring a greater understanding of ALS patients closer to the research studies that can lead to new hypotheses and approaches.

Key facts

Study ID

NCT05067179

Run by

University of Illinois at Chicago

People needed

40

Starts

2020-09-01

Expected to finish

2030-01-01

Last updated by the study team

2026-07-08

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients over the age of 18
• Established diagnosis of ALS
• Able and willing to give written informed consent and must authorize release and use of protected health information

You may not qualify if…

• Patients below the age of 18
• No diagnosis of ALS

Where it is running

• University of Illinois at Chicago — Chicago, Illinois, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.